Pro Power Knight Plus Capsule Recalled for Undeclared Pharmaceutical Ingredients
Pro Power Knight Plus capsules contain undeclared sildenafil and tadalafil, prescription ingredients not listed on the label. The product was marketed as an unapproved drug and poses safety risks.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: FDA Class I recall. The product contains undeclared sildenafil and tadalafil, prescription pharmaceutical ingredients marketed without FDA approval, which meets the threshold for severe classification per FDA standards.
Plain-English summary
Pro Power Knight Plus capsules, 2550mg, manufactured by Gadget Island, Inc and distributed by Beyond Health and youth Inc (Seattle, WA 98110), have been recalled by the FDA due to serious safety concerns.
The product was found to contain undeclared sildenafil and tadalafil, which are pharmaceutical ingredients approved by the FDA only in specific prescription products for male sexual enhancement. Because these active ingredients were not declared on the label and the product lacks FDA approval, it is classified as an unapproved drug. The undisclosed presence of these prescription-strength ingredients poses health risks, particularly to consumers who may be unaware of taking them or who may have conditions or take medications that interact dangerously with these substances.
The affected product is available nationwide in the USA. Consumers who have purchased this product should stop using it immediately and consult a healthcare provider if they have taken it and experience any adverse effects.
The recalled product
- Product
- Pro Power Knight Plus capsule, 2550mg, 1-count blister card, Distributed by Beyond Health and youth Inc, Seattle, WA 98110, UPC 4 94922 90522 0.
- Manufacturer
- Gadget Island, Inc
- Hazard
- undeclared-sildenafil
- undeclared-tadalafil
- unapproved-drug
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- No lot number
- Exp: 06/2026
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- HighBeak & Skiff Alcohol Antiseptic Sanitizer recalled for acetaldehyde contamination
FDA (Drugs) · 2026-06-17
- SevereCIMZIA injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-05-27
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27